Vincent Miles
Executive Director at Abingworth
Boston, Massachusetts
Overview
Work Experience
Executive Director
2022 - Current
Partner
2007 - 2022
Representing Abingworth, have served on the Boards of Chiasma, Dicerna Pharmaceuticals, Dynex Technologies, Hydra Biosciences, IFM Therapeutics, IFM Due, IFM Tre, IFM Quattro, Magellan Diagnostics, Personalis and PrimeraDx, and as a Board observer at Atsena Therapeutics and Nido Biosciences. Abingworth is a life-sciences venture capital firm that invests mainly in companies discovering and developing novel therapeutics for unmet clinical needs.
Senior VP, Business Development
2003 - 2007
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Raised $3,884,600,000.00 from Blackstone Life Sciences, Regeneron, Genzyme and Takeda.
VP, Business Development, Technology Management
1997 - 2003
Director, Office of Technology Transfer
1996 - 1997
Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research.
Raised $67,079,019.00 from Llama, Hyundai Hope On Wheels, Hyundai Hope On Wheels, Break Through Cancer, Paula and Rodger Riney Foundation, Massachusetts Life Sciences Center and Massachusetts Life Sciences Center.
VP, R&D and Business Development
1992 - 1996
VP, International Marketing (Molecular Biology Division)
1989 - 1992
VP, R&D (Molecular Biology Division)
1986 - 1990
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.
R&D and Business Development
1978 - 1986
Higher Scientific Officer
1975 - 1978